Zobrazeno 51 - 60
of 867
pro vyhledávání: '"Norio Ohmagari"'
Autor:
Kei Yamamoto, Yusuke Asai, Issaku Nakatani, Kenichi Hayashi, Hidenori Nakagawa, Koh Shinohara, Shinichiro Kanai, Michitsugu Shimatani, Masaya Yamato, Nobuyuki Shimono, Tsuyoshi Kitaura, Nobuhiro Komiya, Atsushi Nagasaka, Takahiro Mikawa, Akihiro Manabe, Takashi Matono, Yoshihiro Yamamoto, Taku Ogawa, Satoshi Kutsuna, Norio Ohmagari
Publikováno v:
Tropical Diseases, Travel Medicine and Vaccines, Vol 8, Iss 1, Pp 1-11 (2022)
Abstract Background Awareness of pre-travel consultations (PTCs) and prevention methods for overseas travel-related diseases, and the understanding of PTCs among Japanese travelers and medical professionals remains low in Japan. A multicenter registr
Externí odkaz:
https://doaj.org/article/d7332d86024d40448017d1f665a952e7
Autor:
Akahito Sako, Yoshiaki Gu, Yoshinori Masui, Kensuke Yoshimura, Hidekatsu Yanai, Norio Ohmagari
Publikováno v:
PLoS ONE, Vol 18, Iss 10, p e0291673 (2023)
BackgroundBoth physicians and patients are proactive towards managing seasonal influenza in Japan and six drugs are approved. Although many countries have national influenza surveillance systems, data on nationwide prescription practices of anti-infl
Externí odkaz:
https://doaj.org/article/c46a7e338eda4ad5adf6b8ea2efbea9c
Autor:
Satoshi Ide, Masahiro Ishikane, Kensuke Aoyagi, Akane Ono, Yusuke Asai, Shinya Tsuzuki, Yoshiki Kusama, Yoshiaki Gu, Eiichi Kodama, Norio Ohmagari
Publikováno v:
PLoS ONE, Vol 18, Iss 6 (2023)
Macrolide usage in Japan exceeds that in Europe and the United States. Investigating the actual conditions in which macrolides are used is important for identifying further interventions for appropriate antimicrobial use; however, this situation has
Externí odkaz:
https://doaj.org/article/7c8a8761531b486ca54861716cc46049
Autor:
Junko Terada-Hirashima, Yuki Takamatsu, Yosuke Shimizu, Yukari Uemura, Junko S. Takeuchi, Noriko Tomita, Kouki Matsuda, Kenji Maeda, Shohei Yamamoto, Ami Fukunaga, Norio Ohmagari, Ayako Mikami, Kengo Sonoda, Mugen Ujiie, Hiroaki Mitsuya, Wataru Sugiura
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Although vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) induce effective immune responses, vaccination with booster doses is necessary because of waning immunity. We conducted an open-label, non-rand
Externí odkaz:
https://doaj.org/article/9e1eb62a8e1847b9bf4013d1581744ff
Autor:
Jiaqi Li, Takeshi Nakagawa, Masayo Kojima, Akihiko Nishikimi, Haruhiko Tokuda, Kunihiro Nishimura, Jun Umezawa, Shiori Tanaka, Manami Inoue, Norio Ohmagari, Koushi Yamaguchi, Kazuyoshi Takeda, Shohei Yamamoto, Maki Konishi, Kengo Miyo, Tetsuya Mizoue
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0283658 (2023)
Patients with underlying medical conditions are at high risk of developing serious symptoms of the coronavirus disease 2019 than healthy individuals; therefore, it is necessary to evaluate the immune response to vaccination among them to formulate pr
Externí odkaz:
https://doaj.org/article/3ab67df699104ddf86b4180004edbd59
Autor:
Kei Yamamoto, Yusuke Ohsiro, Tetsuya Suzuki, Michiyo Suzuki, Sayaka Miura, Maki Nagashima, Noriko Iwamoto, Junko S Takeuchi, Moto Kimura, Wataru Sugiura, Satoru Nebuya, Masato Kurokawa, Norio Ohmagari
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0279897 (2023)
Although biomarkers to predict coronavirus disease 2019 (COVID-19) severity have been studied since the early pandemic, no clear guidelines on using them in clinical practice are available. Here, we examined the ability of four biomarkers to predict
Externí odkaz:
https://doaj.org/article/5463c902ff7d46c3adf5ee81242c5cdb
Autor:
Naoya Itoh, Takanori Kawabata, Nana Akazawa, Daichi Kawamura, Hiromi Murakami, Yuichi Ishibana, Eiichi N Kodama, Norio Ohmagari
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0281518 (2023)
Oral third-generation cephalosporins (3GCs) are not recommended for use owing to their low bioavailability and the risk of emergence of resistant microorganisms with overuse. A standardized and effective method for reducing their use is lacking. Here
Externí odkaz:
https://doaj.org/article/12e6e5ce1f5449b8a3bdf12b2f85a240
Autor:
Yuki Takamatsu, Kazumi Omata, Yosuke Shimizu, Noriko Kinoshita-Iwamoto, Mari Terada, Tetsuya Suzuki, Shinichiro Morioka, Yukari Uemura, Norio Ohmagari, Kenji Maeda, Hiroaki Mitsuya
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 6 (2022)
ABSTRACT Secretory immunoglobulin A (IgA) plays a crucial role in mucosal immunity for preventing the invasion of exogenous antigens; however, little is understood about the neutralizing activity of serum IgA. Here, to examine the role of IgA antibod
Externí odkaz:
https://doaj.org/article/f8a40be1b709422cb9e74e88a51ebe87
Autor:
Hanako Takahata, Kazunari Onishi, Hidetoshi Nomoto, Noriko Iwamoto, Kuniyoshi Hayashi, Narumi Hori, Satoshi Kutsuna, Eiichi N. Kodama, Norio Ohmagari
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
We conducted a cross-sectional study using a structured questionnaire in three major Japanese cities from August 03 to 24, 2020 to clarify the current situation of health checkups, including vaccine-preventable diseases (VPDs), among international st
Externí odkaz:
https://doaj.org/article/778987275e6349ec9178143563bbd7bf
Autor:
Makoto Inada, Masahiro Ishikane, Mari Terada, Akihiro Matsunaga, Kenji Maeda, Noriko Iwamoto, Mugen Ujiie, Satoshi Kutsuna, Shinichiro Morioka, Yukihito Ishizaka, Hiroaki Mitsuya, Norio Ohmagari
Publikováno v:
International Journal of Infectious Diseases, Vol 119, Iss , Pp 18-20 (2022)
We present a case of a 58-year-old Japanese man with a history of 2 previous COVID-19 infections, who received 2 doses of mRNA-1273 vaccine. We are not aware of any previous study regarding antibody tendency after 2 infections and 2 vaccinations. We
Externí odkaz:
https://doaj.org/article/b632f2e4cf7a4f58be3154057fba81a7